ArticleJournal of the renin-angiotensin-aldosterone system : JRAAS

Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy.

Ye-Ping Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.